Panacea Biotec

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE922B01023
  • NSEID: PANACEABIO
  • BSEID: 531349
INR
344.15
-3.05 (-0.88%)
BSENSE

Dec 05

BSE+NSE Vol: 44.74 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
27.78
27.78
27.78
27.78
27.78
27.92
Share Warrants & Outstandings
Total Reserve
807.01
814.27
815.82
848.86
-256.47
138.87
Shareholder's Funds
834.79
842.05
843.60
876.64
-228.69
198.79
Minority Interest
-4.17
-3.82
-3.50
-2.98
-3.00
-3.04
Long-Term Borrowings
22.21
20.99
20.22
34.16
819.53
738.62
Secured Loans
0.00
0.00
0.24
0.29
759.50
708.64
Unsecured Loans
22.21
20.99
19.98
33.87
60.03
29.98
Deferred Tax Assets / Liabilities
23.28
22.55
20.37
-23.75
-0.15
-1.95
Other Long Term Liabilities
11.31
22.28
34.24
45.59
194.41
86.73
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
35.34
27.80
26.55
29.16
30.65
42.74
Total Non-Current Liabilities
92.14
93.61
99.22
85.10
959.99
740.66
Current Liabilities
Trade Payables
225.76
145.56
177.32
234.72
246.66
198.85
Other Current Liabilities
104.88
127.73
116.21
505.64
104.64
242.57
Short Term Borrowings
0.00
0.00
0.06
0.05
84.45
3.57
Short Term Provisions
36.36
35.69
36.14
35.95
13.35
6.96
Total Current Liabilities
366.99
308.98
329.73
776.37
449.09
451.95
Total Liabilities
1,289.75
1,240.82
1,271.17
1,735.12
1,177.38
1,388.35
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
1,327.84
1,311.87
1,330.83
1,317.48
1,261.62
1,274.64
Less: Accumulated Depreciation
776.73
742.62
730.88
695.41
652.92
617.25
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
551.12
569.26
599.95
622.07
608.70
657.39
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
93.51
74.72
28.01
4.91
21.24
9.51
Intangible assets under development
34.54
26.78
14.32
12.35
13.18
14.50
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
15.87
12.66
0.07
0.07
0.07
5.58
Long Term Loans & Advances
46.53
70.96
56.76
21.46
17.62
17.51
Other Non Current Assets
3.01
0.97
9.74
123.70
5.61
0.60
Total Non-Current Assets
744.57
755.35
708.85
784.56
666.41
705.08
Current Assets Loans & Advances
Current Investments
3.15
40.36
13.42
5.00
0.00
0.00
Inventories
213.67
177.94
202.09
212.72
174.14
147.69
Sundry Debtors
72.56
57.42
60.09
81.66
84.68
68.52
Cash and Bank
106.97
122.00
225.99
583.28
135.79
89.75
Other Current Assets
8.27
7.12
6.42
6.41
48.38
332.60
Short Term Loans and Advances
140.56
80.63
54.31
61.49
67.98
44.71
Total Current Assets
545.18
485.47
562.32
950.55
510.97
683.27
Net Current Assets (Including Current Investments)
178.19
176.49
232.59
174.19
61.88
231.32
Total Current Assets Excluding Current Investments
542.03
445.11
548.90
945.55
510.97
683.27
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
1,289.75
1,240.82
1,271.17
1,735.12
1,177.38
1,388.35
Contingent Liabilities
367.09
369.39
655.75
368.17
406.99
366.93
Total Debt
22.21
20.99
20.16
34.10
735.08
491.20
Book Value per share (adjusted)
132.76
133.94
134.2
139.59
-40.87
21.7157955577574
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is 5.81% vs 3.81% in Mar 2024

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is -49.24% vs -34.93% in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 0.10% vs 2.55% in Mar 2024

stock-summary

Investments

YoY Growth in year ended Mar 2025 is 25.36% vs 17,985.71% in Mar 2024

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 12.30% vs -13.67% in Mar 2024

Compare Balance Sheet Results of Panacea Biotec
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
27.78
109.58
-81.80
-74.65%
Share Warrants & Outstandings
Total Reserve
807.01
1,046.65
-239.64
-22.90%
Shareholder's Funds
834.79
1,156.23
-321.44
-27.80%
Minority Interest
-4.17
30.73
-34.90
-113.57%
Long-Term Borrowings
22.21
25.76
-3.55
-13.78%
Secured Loans
0.00
5.76
-5.76
-100.00%
Unsecured Loans
22.21
20.00
2.21
11.05%
Deferred Tax Assets / Liabilities
23.28
6.98
16.30
233.52%
Other Long Term Liabilities
11.31
17.91
-6.60
-36.85%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
35.34
39.85
-4.51
-11.32%
Total Non-Current Liabilities
92.14
90.49
1.65
1.82%
Current Liabilities
Trade Payables
225.76
363.30
-137.54
-37.86%
Other Current Liabilities
104.88
64.12
40.76
63.57%
Short Term Borrowings
0.00
53.63
-53.63
-100.00%
Short Term Provisions
36.36
19.60
16.76
85.51%
Total Current Liabilities
366.99
500.65
-133.66
-26.70%
Total Liabilities
1,289.75
1,778.10
-488.35
-27.46%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1,327.84
791.10
536.74
67.85%
Less: Accumulated Depreciation
776.73
328.07
448.66
136.76%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
551.12
463.03
88.09
19.02%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
93.51
28.34
65.17
229.96%
Intangible assets under development
34.54
0.00
34.54
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
15.87
7.17
8.70
121.34%
Long Term Loans & Advances
46.53
94.47
-47.94
-50.75%
Other Non Current Assets
3.01
0.23
2.78
1,208.70%
Total Non-Current Assets
744.57
618.73
125.84
20.34%
Current Assets Loans & Advances
Current Investments
3.15
77.81
-74.66
-95.95%
Inventories
213.67
299.96
-86.29
-28.77%
Sundry Debtors
72.56
324.76
-252.20
-77.66%
Cash and Bank
106.97
49.36
57.61
116.71%
Other Current Assets
8.27
70.34
-62.07
-88.24%
Short Term Loans and Advances
140.56
337.14
-196.58
-58.31%
Total Current Assets
545.18
1,159.37
-614.19
-52.98%
Net Current Assets (Including Current Investments)
178.19
658.72
-480.53
-72.95%
Total Current Assets Excluding Current Investments
542.03
1,081.56
-539.53
-49.88%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
1,289.75
1,778.10
-488.35
-27.46%
Contingent Liabilities
367.09
18.32
348.77
1,903.77%
Total Debt
22.21
79.39
-57.18
-72.02%
Book Value per share (adjusted)
132.76
21.10
111.66
529.19%
Annual - Borrowings
Borrowings 22.21 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 5.81% vs 3.81% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 11.31 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -49.24% vs -34.93% in Mar 2024

Annual - Fixed Assets
Fixed Assets 644.63 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 0.10% vs 2.55% in Mar 2024

Annual - Investments
Investments 15.87 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 25.36% vs 17,985.71% in Mar 2024

Annual - Current Assets
Current Assets 545.18 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 12.30% vs -13.67% in Mar 2024